#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Niemann-Pick disease Still's disease Fibrosarcoma metastatic Erythema Hyperinsulinism Superficial vein thrombosis Thromboangiitis obliterans Liposarcoma metastatic Central nervous system lymphoma Factor VIII deficiency Dementia PIK3CA related overgrowth spectrum Follicle centre lymphoma follicular grade I, II – III Cystic fibrosis respiratory infection suppression Transferrin decreased More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Life with Disease Hypereosinophilic syndrome – Life with Disease Medulloblastoma recurrent – Trials in Disease Richter’s syndrome – Life with Disease Acquired haemophilia Osteosarcoma metastatic – Life with Disease Pleural mesothelioma malignant – Diagnostics Leukoencephalopathy Hereditary angioedema – Life with Disease Angelman’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naxitamab Tamoxifen Maralixibat Chloride Ustekinumab Glofitamab ALG-000184 Florbetaben (18F) Evx-01 Cedazuridine Naproxen Utreglutide Octreotide Hydrochloride Emiplacel Ferumoxytol Sodium Iodide (123 I) Op-1250 Metoprolol Tartrate Ciprofloxacin Hydrochloride ANERATRIGINE MESILATE Goserelin More therapies…

    Learn about Your Condition

    Normal pressure hydrocephalus Familial mediterranean fever Paresis Left ventricular failure BK virus infection Bone hypertrophy Breast cancer stage I Hyperphagia Thyroidectomy Myocarditis post infection Synovial sarcoma Embolism Lichenoid keratosis Mite allergy Acute lymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Wojewodzki W Opolu Sp. z o.o.

Szpital Wojewodzki W Opolu Sp. z o.o.

Ul. Katowicka 64, Opole, 45-061, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Vincristine
    • Cyclophosphamide
    Austria Belgium Czechia France Germany Italy +3

  • Study on Extended Access to Momelotinib for Patients with Myelofibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    Belgium Bulgaria Denmark France Germany Hungary +4

  • Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Sapablursen
    Poland

  • Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Chlorambucil
    • Obinutuzumab
    Belgium France Germany Hungary Italy Lithuania +3
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!